Evidence map›Paper›PMID 41309593›Full record

ArticleNature communications2025

Dynamic assembly of a large multidomain ribozyme visualized by cryo-electron microscopy.

Shekhar Jadhav, Mauro Maiorca, Jacopo Manigrasso, Spandan Saha, Auriane Rakitch, Stefano Muscat, Thomas Mulvaney, Marco De Vivo, Maya Topf, Marco Marcia

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shekhar JadhavEuropean Molecular Biology Laboratory (EMBL) Grenoble, 71 Avenue des Martyrs, Grenoble, France.
Mauro Maiorca *Centre for Structural Systems Biology (CSSB), Hamburg, Germany.
Jacopo Manigrasso *Laboratory of Molecular Modelling & Drug Discovery, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, Italy.ORCID http://orcid.org/0000-0003-4076-8930
Spandan SahaDepartment of Cell and Molecular Biology, Uppsala University, Husargatan 3, Uppsala, Sweden.ORCID http://orcid.org/0009-0000-1090-4490
Auriane RakitchDepartment of Cell and Molecular Biology, Uppsala University, Husargatan 3, Uppsala, Sweden.
Stefano MuscatLaboratory of Molecular Modelling & Drug Discovery, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, Italy.ORCID http://orcid.org/0000-0002-2733-8357
Thomas MulvaneyResearch Department Integrative Virology, Leibniz-Institut für Virologie (LIV), Hamburg, Germany.ORCID http://orcid.org/0000-0002-4373-6160
Marco De VivoLaboratory of Molecular Modelling & Drug Discovery, Istituto Italiano di Tecnologia, Via Morego 30, Genoa, Italy. marco.devivo@iit.it.ORCID http://orcid.org/0000-0003-4022-5661
Maya TopfCentre for Structural Systems Biology (CSSB), Hamburg, Germany. maya.topf@cssb-hamburg.de.ORCID http://orcid.org/0000-0002-8185-1215
Marco MarciaEuropean Molecular Biology Laboratory (EMBL) Grenoble, 71 Avenue des Martyrs, Grenoble, France. marco.marcia@icm.uu.se.ORCID http://orcid.org/0000-0003-2430-0713

Funding

Agence Nationale de la Recherche (French National Research Agency) ANR-17-EURE-0003Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 28746Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) IG 30631Deutsche Forschungsgemeinschaft (German Research Foundation) CRC 1648 (Project B01)EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) project: TargetRNA, n. 101168667Fondation ARC pour la Recherche sur le Cancer (ARC Foundation for Cancer Research) PJA-20191209284Fondation Innovations en Infectiologie (FINOVI Foundation) AAP15French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INBS-0005-02Vetenskapsrådet (Swedish Research Council) 2024-04107Wellcome Trust
6 · The paper itself

Abstract

Many RNAs rely on their 3D structures for function. While acquiring functional 3D structures, certain RNAs form misfolded, non-functional states ('kinetic traps'). Instead, other RNAs sequentially assemble into their functional conformations over pre-folded scaffolds. Elucidating the principles of RNA sequential assembly is thus important to understand how RNAs avoid the formation of misfolded, non-functional states. Integrating single-particle electron cryomicroscopy (cryo-EM), image processing, in solution small-angle X-ray scattering (SAXS), EM-driven molecular dynamics (MD) simulations, structure-based mutagenesis, and enzymatic assays, we have visualized the sequential multidomain assembly of a self-splicing ribozyme of biomedical and bioengineering significance. Our work reveals a distinct dynamic interplay of helical subdomains in the ribozyme's 5'-terminal scaffold, which acts as a gate to control the docking of 3'-terminal domains. We identify specific conserved and functionally important secondary structure motifs as the key players for orchestrating the energetically inexpensive conformational changes that lead to the productive formation of the catalytic pocket. Our work provides a near-atomic resolution molecular movie of a large multidomain RNA assembling into its functionally active conformation and establishes a basis for understanding how RNA avoids the formation of non-functional 'kinetic traps'.

Indexed as

Cryoelectron MicroscopyRNA, CatalyticMolecular Dynamics SimulationNucleic Acid ConformationRNA FoldingScattering, Small AngleX-Ray DiffractionRNA, Catalytic

Identifiers

PMID41309593
PMCPMC12660903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.